A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Economic considerations in the management of Alzheimer's diseaseDiet and Alzheimer’s disease risk factors or prevention: the current evidenceVitamin C and Vitamin E for Alzheimer's DiseasePredictors of mortality in patients with Alzheimer's disease living in nursing homesPrevention of Alzheimer's diseasePharmacological interventions for cognitive decline in people with Down syndromePharmacological interventions for cognitive decline in people with Down syndromeAntioxidant vitamin and mineral supplements for preventing age-related macular degenerationVitamin E for Alzheimer's dementia and mild cognitive impairmentVitamin E for Alzheimer's disease and mild cognitive impairmentAntioxidant vitamin and mineral supplements for preventing age-related macular degenerationAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesMonoamine oxidase: from genes to behaviorNovel therapeutics for Alzheimer's disease: an updateMAO-inhibitors in Parkinson's DiseaseA critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's diseaseFenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's diseaseCurrent pharmacologic options for patients with Alzheimer's diseaseModulation of radiation-induced disturbances of antioxidant defense systems by ginsanNeuroprotection and antioxidantsCurrent status of biomarker research in neurologyPolyphenolic Antioxidants and Neuronal RegenerationAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsEndoplasmic Reticulum Stress and Associated ROSThe Role of Oxidative Stress in Neurodegenerative DiseasesThe Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersThe role of lipid peroxidation in neurological disordersA practical algorithm for managing Alzheimer's disease: what, when, and why?Effects of vitamin E on cognitive performance during ageing and in Alzheimer's diseaseMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionThe 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotypeAlzheimer's pathogenesis and its link to the mitochondrionThe roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic reviewA review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's diseaseTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesThe Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s DiseaseVitamin E, Turmeric and Saffron in Treatment of Alzheimer's DiseaseInflammation and Alzheimer's disease
P2860
Q21090716-186718BC-AF0B-4BCC-AC51-625FE9B432B1Q22241448-246F3FBC-A201-415D-BB5D-CB95B135C6A0Q22241476-B0ECEE3C-769A-4C5C-AE6A-6DB3D6220B61Q22241556-C6F0E2CA-C890-47F2-A658-B32E18129FB9Q22242018-7BCD1122-D4AF-4B65-8B9F-8D8783B645AEQ22248031-3FBF84E0-B81B-4011-8077-88C65CEB8D2DQ24186316-1E2D0352-3BA6-4306-B2A0-8724C3F4BF1DQ24188311-94D41EAB-D8F3-4EF4-A61B-B758B9720B7DQ24202679-A6EC4737-E2B5-4C6C-8AB6-7594BFFE1630Q24202844-103B998A-41FF-42B6-B1B0-27DFA5AFACA3Q24241955-15F768E4-D7A9-41BA-A956-1EDC8EC3E4E0Q24242709-72E4D4E2-B59C-447A-B521-A758F269F143Q24242944-D57041A2-66A0-450D-A9F7-0BEFF53E82D0Q24614980-0E5FBA29-4E4F-4EF0-86B8-E929091028C9Q24620383-1D59E124-A9D0-46B9-B647-EA3FB96DACDCQ24629770-13F460CF-6C9E-4F5F-B707-A8B740062D16Q24634751-013AB2EE-211F-45FE-9C10-92ADB2822485Q24656549-B5613430-A3A1-431D-932F-94614706E164Q24800530-B65243B9-B42D-44B5-A1BF-363FD35E5328Q24812390-CEFEA90C-D6D9-4DC6-8F4A-54B7BC2B9971Q26740098-0A9C8FF3-16A8-41CD-94A5-C04CE3E820FFQ26744505-1EE13DA8-E78B-4139-B323-533B31F639DBQ26745945-5F19D3E5-A413-4F3A-928B-EAB56B34FC1BQ26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86Q26767386-BECBD7E7-A79D-4F24-901E-9A5FCC4FB52CQ26771758-B17F484D-33B6-4537-A2D9-553FFE603BDBQ26822972-D7701E1B-A877-4B08-A325-EC275FCA2254Q26825442-6692A20A-209E-4285-917E-F8C509C6B40BQ26829767-73112B3C-3F9D-4999-A78B-75504C0232E8Q26859831-99DF5BA3-EA28-4AFD-91A6-7358B851E811Q26864433-3355A213-BEA9-4826-9BBA-46BE7A0D35D5Q26865358-9E09B922-3539-4767-B6FA-45AABF8D44CFQ26999358-2503A944-3AE3-4BD7-BE4E-DEF59C046D10Q27000255-F9016396-ADE2-4AE7-860D-857AAEDB1924Q27008396-A0A5CDC2-522A-44B6-B08C-FA11514F7718Q27311651-8196989A-C88B-4D21-8FF4-28098523727BQ27338799-DCE5BA1B-A95F-4E43-88C2-F89A9374321DQ28074531-E4E9AB5F-FF1B-4823-840B-3D2C465D11CDQ28080306-6AB0113D-12E8-4E4B-9DCA-3680A8D81EAEQ28138617-F6488070-BF30-458B-87DF-B7E948D1B9AF
P2860
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
A controlled trial of selegili ...... r's Disease Cooperative Study.
@en
A controlled trial of selegili ...... r's Disease Cooperative Study.
@nl
type
label
A controlled trial of selegili ...... r's Disease Cooperative Study.
@en
A controlled trial of selegili ...... r's Disease Cooperative Study.
@nl
prefLabel
A controlled trial of selegili ...... r's Disease Cooperative Study.
@en
A controlled trial of selegili ...... r's Disease Cooperative Study.
@nl
P2093
P1476
A controlled trial of selegili ...... r's Disease Cooperative Study.
@en
P2093
C W Cotman
E Pfeiffer
L S Schneider
M Grundman
M R Klauber
P304
P356
10.1056/NEJM199704243361704
P407
P577
1997-04-01T00:00:00Z